Expression of β-catenin in rat oral epithelial dysplasia induced by 4-nitroquinoline 1-oxide

Oral Oncology

Volumn 38, Issue 8, 2002, Pages 772-778

  Sato, Kazumichi ^a   Okazaki, Yuichiro ^a   Tonogi, Morio ^a   Tanaka, Yoichi ^a   Yamane, Gen Yuki ^a  

^a TOKYO DENTAL COLLEGE   (Japan)

Author keywords

Catenin; 4 Nitroquinoline 1 oxide; Dysplasia; Oral carcinogenesis; Squamous cell carcinoma

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; BETA CATENIN; KI 67 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CYTODIAGNOSIS; CANCER INVASION; CANCER MODEL; CELL NUCLEUS; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; CYTOPLASM; DRUG INDUCED DISEASE; EARLY CANCER; EPITHELIUM DYSPLASIA; EVALUATION; EXON; GENETIC ANALYSIS; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MALE; MOUTH MUCOSA; MUTATION; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; TONGUE;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; BETA CATENIN; CARCINOGENS; CYTOSKELETAL PROTEINS; EPITHELIAL CELLS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; RATS; RATS, SPRAGUE-DAWLEY; TONGUE NEOPLASMS; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037001735     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(02)00044-1     Document Type: Article

References (27)

1. Speight P.M., Morgan P.R. The natural history and pathology of oral cancer and precancer. Community Dent Health. 10(Suppl 1):1993;31-41.
2. Imai F.L., Uzawa K., Shiiba M., Watanabe T., Miya T., Kubosawa H., Kondo Y., Tanzawa H. Evidence of multi-step oncogenesis of oral squamous cell carcinoma. Oncol Rep. 5(6):1998;1489-1491.
3. Okazaki Y, Yamane G, Tonogi M, Tanaka Y. Investigation of environmental factors for diagnosing malignant potential in oral epitherial dysplasia. Oral Oncol 2002;38(6):42-53.
4. Takaki T. Cell proliferation in the carcinogenic process of tongue carcinoma in rats induced by 4-nitroquinoline-1-oxide. 2. Relation between morphology microvascular architecture and cell proliferation in keratinized lesions and squamous cell carcinoma. Shikwa Gakuho. 86(5):1986;777-804.
5. Ohne M., Satoh T., Yamada S., Takai H. Experimental tongue carcinoma of rats induced by oral administration of 4-nitroquinoline 1-oxide (4NQO) in drinking water. Oral Surg Oral Med Oral Pathol. 59(6):1985;600-607.
6. Osugi Y. p53 expression in various stages of 4-nitroquinoline 1-oxide induced carcinoma in the rat tongue. J Osaka Dent Univ. 30(1-2):1996;29-35.
7. Polakis P. Wnt signaling and cancer. Genes Dev. 14(15):2000;1837-1851.
8. Lo Muzio L. A possible role for the WNT-1 pathway in oral carcinogenesis. Crit Rev Oral Biol Med. 12(2):2001;152-165.
9. Aberle H., Bauer A., Stappert J., Kispert A., Kemler R. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16(13):1997;3797-3804.
10. Morn P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., Kinzler K.W. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 275(5307):1997;1787-1790.
11. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., Kinzler K.W. Identification of cMYC as a target of the APC pathway. Science. 281(5382):1998;1509-1512.
12. Tetsu O., McCormick F. Beta-catenin regulates expression of cyclin Dl in colon carcinoma cells. Nature. 398(6726):1999;422-426.
13. Iwao K., Nakamori S., Kameyama M., Imaoka S., Kinoshita M., Fukui T., Ishiguro S., Nakamura Y., Miyoshi Y. Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res. 58(5):1998;1021-1026.
14. Iwamoto M., Ahnen D.J., Franklin W.A., Maltzman T.H. Expression of beta-catenin and full-length APC protein in normal and neoplastic colonic tissues. Carcinogenesis. 21(11):2000;1935-1940.
15. Shinohara A., Yokoyama Y., Wan X., Takahashi Y., Mori Y., Takami T., Shimokawa K., Tamaya T. Cytoplasmic/nuclear expression without mutation of exon 3 of the beta-catenin gene is frequent in the development of the neoplasm of the uterine cervix. Gynecol Oncol. 82(3):2001;450-455.
16. Murata M., Miyoshi Y., Ohsawa M., Shibata K., Ohta T., Imai Y., Nishikawa M., Iwao K., Tateishi H., Shimano T., Kobayashi T., Nakamura Y. Accumulation of beta-catenin in the cytoplasm and the nuclei during the early hepatic tumorigenesis. Hepatol Res. 21(2):2001;126-135.
17. Bian Y.S., Osterheld M.C., Bosman F.T., Fontolliet C., Benhattar J. Nuclear accumulation of beta-catenin is a common and early event during neoplastic progression of Barrett esophagus. Am J Clin Pathol. 114(4):2000;583-590.
18. Takahashi M., Mutoh M., Kawamori T., Sugimura T., Wakabayashi K. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. Carcinogenesis. 21(7):2000;1319-1327.
19. Tsujiuchi T., Tsutsumi M., Sasaki Y., Murata N., Konishi Y. Mutations of adenomatous polyposis coli and beta-catenin genes during progression of lung tumors induced by N-nitrosobis(2-hydroxypropyl)amine in rats. Cancer Res. 60(23):2000;6611-6616.
20. Yamada Y., Yoshimi N., Hirose Y., Matsunaga K., Katayama M., Sakata K., Shimizu M., Kuno T., Mori H. Sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res. 61(5):2001;1874-1878.
21. Lo Muzio L., Staibano S., Pannone G., Grieco M., Mignogna M.D., Cerrato A., Testa N.F., De Rosa G. Beta- and gamma-catenin expression in oral squamous cell carcinomas. Anticancer Res. 19(5B):1999;3817-3826.
22. Pukkila M.J., Virtaniemi J.A., Kumpulainen E.J., Pirinen R.T., Johansson R.T., Valtonen H.J., Juhola M.T., Kosma V.M. Nuclear beta catenin expression is related to unfavourable outcome in oropharyngeal and hypophaiyngeal squamous cell carcinoma. J Clin Pathol. 54(1):2001;42-47.
23. Suzui M., Ushijima T., Dashwood R.H., Yoshimi N., Sugimura T., Mori H., Nagao M. Frequent mutations of the rat beta-catenin gene in colon cancers induced by methylazoxymethanol acetate plus 1-hydroxyanthraquinone. Mol Carcinog. 24(3):1999;232-237.
24. Bukholm I.K., Nesland J.M., Borresen-Dale A.L. Re-expression of E-cadherin, aipha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients. J Pathol. 190(1):2000;15-19.
25. Polakis P. The adenomatous polyposis coli (APC) tumor suppressor. Biochim Biophys Acta. 1332(3):1997;F127-F147.
26. Liu W., Dong X., Mai M., Seelan R.S., Taniguchi K., Krishnadath K.K., Halling K.C., Cunningham J.M., Boardman L.A., Qian C., Christensen E., Schmidt S.S., Roche P.C., Smith D.I., Thibodeau S.N. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet. 26(2):2000;146-147.
27. Suzui M., Sugie S., Mori H., Okuno M., Tanaka T., Moriwaki H. Different mutation status of the beta-catenin gene in carcinogeninduced colon, brain, and oral tumors in rats. Mol Carcinog. 32(4):2001;206-212.